Stadtallendorf, Germany

Lothar Schwink

This inventor holds 34 USPTO granted patents and 7 published patent applications and 16 EPO patents, primarily in GPR119 Modulators. Top assignees: Sanofi, Sanofi-A Ventis Deutschland Gmbh, Aventis Pharma Deutschland, Gmbh. Active years: 2003-2019.

USPTO Granted Patents = 34 

% Patents Active = 26.5

 

Average Co-Inventor Count = 5.8

ph-index = 8

Forward Citations = 305(Granted Patents)


Location History:

  • Stadtallendorf, DE (2003 - 2013)
  • Frankfurt-am-Main, DE (2013 - 2019)

Company Filing History:


Years Active: 2003-2019

Loading Chart...
Loading Chart...
Areas of Expertise:
GPR119 Modulators
Diabetes Treatments
Heterocyclic Compounds
Amino Alcohols
Substituted Indanones
Polycyclic Amines
Pyrrolidinone Derivatives
Aryldihydroisoquinolinones
Bicyclic Compounds
Pharmaceutical Formulations
Therapeutic Uses
Medicinal Chemistry
34 patents (USPTO):Explore Patents

Title: The Innovative Mind of Lothar Schwink

Introduction: Lothar Schwink is a renowned inventor hailing from Stadtallendorf, Germany, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Lothar Schwink holds several patents in various technological domains, showcasing his versatility and ingenuity in inventing novel solutions to complex problems.

Career Highlights: Throughout his illustrious career, Lothar Schwink has consistently pushed the boundaries of technological advancement, with his inventions revolutionizing industries and improving the lives of many.

Collaborations: Lothar Schwink has collaborated with leading research institutions, universities, and companies worldwide, demonstrating his ability to work effectively in multidisciplinary teams to bring innovative ideas to life.

Conclusion: Lothar Schwink's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, inspiring the next generation of innovators to push the limits of what is possible.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…